DSAM Partners’s Veracyte VCYT Stock Holding History

DSAM Partners’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,520	Closed	-$213K	–	131
2019 Q1	$213K	Buy	+8,520	New	+$163K	0.03%	79

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

DSAM Partners's VCYT Position: Q2 2019 in Review

DSAM Partners sold out of Veracyte (VCYT) in Q2 2019, closing a stake of 8,520 shares — an estimated $213K sold.

DSAM Partners first reported a position in VCYT in Q1 2019 and held it in 1 quarter. The position peaked at $213K in Q1 2019. 195 funds tracked by Wall St. Rank hold VCYT as of Q2 2019.

DSAM Partners reported no remaining Veracyte position as of Q2 2019 after selling out during the quarter.
DSAM Partners sold 8,520 Veracyte shares in Q2 2019, an estimated $213K.
DSAM Partners first reported a position in Veracyte in Q1 2019 and held it in 1 quarter.
DSAM Partners's Veracyte position peaked at $213K in Q1 2019.
195 funds tracked by Wall St. Rank held Veracyte as of Q2 2019.

Based on DSAM Partners's 13F filing for Q2 2019, filed 14 Aug 2019.